feed,title,long_url,short_url
🔐MarketWatch,ImmunoGen's stock is up 12% after the FDA accepts application for new ovarian-cancer therapy,http://www.marketwatch.com/news/story/immunogens-stock-up-12-after/story.aspx?guid=%7BF9577CE5%2D6457%2D4E8D%2D8040%2D88B90E8831AA%7D&siteid=rss,https://on.mktw.net/3PBjbOy
